2022 Cold Chain Predictions: Creating a new Normal.

COVID-19 vaccines delivered hope for normalcy and excitement grew over convenience-related changes to healthcare, work and more. But the pandemic had other plans. New COVID-19 variants emerged...

Why there is no "one-size-fits-all" approach to bioavailability.

Every drug development project should begin with a TPP - a comprehensive description of the proposed drug product and the characteristics it needs to successfully meet its therapeutic goals.

Understanding HCP Usage of Technology in a Post-Pandemic World through Hidoc.

The COVID-19 pandemic has revolutionized the health care system in India by bringing in multiple digital health technologies as the new normal. As a result, our healthcare systems are charting roadmaps...

CPhI predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity.

CPhI Worldwide releases its beginning of year pharma market predictions for 2022 combining research from over 350 pharma executives and expert views from 10 CPhI contributors.

Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of COVID-19 Vaccine in 2022.

Moderna announced a revised supply agreement with the government of South Korea for 20 million doses of Moderna's COVID-19 vaccine or an updated booster vaccine candidate...

Amyris and Immunitybio Complete Joint Venture for Next Generation Covid-19 RNA Vaccine.

Amyris and ImmunityBi announced the completion of a previously announced joint venture agreement to accelerate the commercialization of a leading next-generation COVID-19 vaccine....

Pfizer and BioNTech Receive U.S. FDA EUA of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older.

Pfizer Inc. and BioNTech SE announced that the U.S. FDA has expanded the EUA of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 12 years of age and older.